Scott F. Sneddon
Vorstandsvorsitzender bei Sharp Edge Labs, Inc.
Profil
Scott F.
Sneddon is currently the President, Chief Executive & Scientific Officer at Sharp Edge Labs, Inc. He previously worked as a Senior Director at Genzyme Corp.
and as a Research Scientist & Group Leader at Pfizer Inc. Dr. Sneddon holds a doctorate degree from Carnegie Mellon University and a graduate degree from The Trustees of Columbia University in The City of New York.
Aktive Positionen von Scott F. Sneddon
Unternehmen | Position | Beginn |
---|---|---|
Sharp Edge Labs, Inc.
Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Scott F. Sneddon
Unternehmen | Position | Ende |
---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Direktor/Vorstandsmitglied | - |
PFIZER, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Scott F. Sneddon
Carnegie Mellon University | Doctorate Degree |
The Trustees of Columbia University in The City of New York | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Sharp Edge Labs, Inc.
Sharp Edge Labs, Inc. Miscellaneous Commercial ServicesCommercial Services Sharp Edge Labs, Inc. develops biosensors to the cellular biology research community. It operates as a assay development company that offers products and services for drug discovery. The firm offers fluorogenic activating protein, which provides accurate and detailed detection method for cellular changes that is amendable to high-throughput screening and detailed follow-up. The company was founded by Alan S. Waggoner and Marcel P. Bruchez in 2010 and is headquartered in Pittsburgh, PA. | Commercial Services |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |